Navigation Links
Notre Dame receives Gates grant for groundbreaking research in global heal
Date:6/3/2014

Marya Lieberman, associate professor of chemistry and biochemistry at the University of Notre Dame, has received a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. Lieberman will pursue an innovative global health and development research project, titled "Printed test cards for rapid field screening of human and animal medications."

Grand Challenges Explorations (GCE) funds individuals worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Lieberman's project is one of over 50 Grand Challenges Explorations Round 12 grants announced today by the Bill & Melinda Gates Foundation.

To receive funding, Marya Lieberman and other Grand Challenges Explorations Round 12 winners demonstrated in a two-page online application a bold idea in one of five critical global heath and development topic areas that included agriculture development, behavior change and looking into animal and human health. Applications for the next Round will be accepted starting September 2014.

Lieberman's team has designed an inexpensive paper test card that can detect low quality medications and apply economic pressure to companies that manufacture or distribute them. The World Health Organization estimates that 10 to 30 percent of human medications are of poor quality and an unknown percentage of animal medications is substandard or falsified. There is little chance that poor quality products will be caught by pharmaceutical buyers or drug regulatory agencies in developing countries, because it is so expensive to collect and test them, so low-quality products continue to harm both people and animals.

Lieberman's team will design a test card to monitor fifty types of human and animal medicines. Testing a sample of a medication is economical and accessible as there is no instrument to purchase, and the results of the test card can be read by eye or with a cell phone photograph. The test cards will enable people who buy large quantities of human or animal medications to steer clear of low-quality products and will help regulators to hold companies responsible for the quality of the medications they sell.

About Grand Challenges Explorations

Grand Challenges Explorations is a US$100 million initiative funded by the Bill & Melinda Gates Foundation. Launched in 2008, over 950 people in more than 55 countries have received Grand Challenges Explorations grants. The grant program is open to anyone from any discipline and from any organization. The initiative uses an agile, accelerated grant-making process with short two-page online applications and no preliminary data required. Initial grants of US$100,000 are awarded two times a year. Successful projects have the opportunity to receive a follow-on grant of up to US$1 million.

Lieberman is a member of Notre Dame's Eck Institute for Global Health which funded her initial exploratory research. She has partnered with the Academic Model Providing Access to Healthcare (AMPATH) which consists of Moi University School of Medicine and Moi Teaching and Referral Hospital in Eldoret, Kenya, and a consortium of North American academic centers. She has also partnered with Sidai which provides quality services to livestock keepers across Kenya. Her work is also supported by Notre Dame's Advanced Diagnostics and Therapeutics which provides diagnostics for the developing world. The PAD project is an evolving collaboration with Toni Barstis, professor of chemistry and physics at Saint Mary's College and with Notre Dame professors Holly Goodson, Patrick Flynn, Christopher Sweet, David Go, and Matthew Champion.


'/>"/>

Contact: Marissa Gebhard
gebhard.3@nd.edu
574-631-4465
University of Notre Dame
Source:Eurekalert

Related medicine news :

1. Second largest research award at Notre Dame fights malaria and dengue fever
2. Notre Dame FCU Sports Grumpy Cat Meme to Attract Gen Y Memberships
3. Notre Dame researchers offer new insights on cancer cell signaling
4. Notre Dame and Harper researchers developing novel method to test for HPV and oral cancers
5. New Notre Dame paper offers insights into how cancer cells avoid cell death
6. Notre Dame researchers scoring a win-win with novel set of concussion diagnostic tools
7. Notre Dame researchers paper examines the biology of tumor-derived microvesicles
8. Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
9. Miriam Hospital receives 8th consecutive award for quality care
10. Dr. Dobryakova of Kessler Foundation receives New Jersey Neuropsychological Society award
11. Richard Sylvester receives European Urology 2014 Platinum Award for Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology: